CEVOSTAMAB for Plasma cell myeloma refractory: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where CEVOSTAMAB was used for Plasma cell myeloma refractory.
Most Reported Side Effects for CEVOSTAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 18 | 28.1% | 4 | 15 |
| Dyspnoea | 7 | 10.9% | 0 | 5 |
| Bronchopulmonary aspergillosis | 6 | 9.4% | 0 | 4 |
| Dizziness | 6 | 9.4% | 0 | 4 |
| Drug interaction | 6 | 9.4% | 0 | 4 |
| Nausea | 6 | 9.4% | 0 | 4 |
| Plasma cell myeloma | 6 | 9.4% | 4 | 4 |
| Pneumonia | 6 | 9.4% | 1 | 6 |
| Pyrexia | 6 | 9.4% | 0 | 4 |
| Febrile neutropenia | 5 | 7.8% | 0 | 4 |
Other Indications for CEVOSTAMAB
Other Drugs Used for Plasma cell myeloma refractory
DEXAMETHASONE (2,276)
POMALIDOMIDE (1,562)
LENALIDOMIDE (1,220)
CARFILZOMIB (1,208)
BORTEZOMIB (848)
DARATUMUMAB (789)
ISATUXIMAB (778)
CYCLOPHOSPHAMIDE (518)
IXAZOMIB (356)
DOXORUBICIN (314)